[1] Phillips MI, Kagiyama S.Angiotensin II as a pro-inflammatory mediator [J].Curr Opin Investig Drugs, 2002, 3 (4):569-577. [2] 汤健, 魏英杰, 主编.心血管活性物质和心血管疾病 [M] 肾素-血管紧张素系统.北京:北京医科大学、协和医科大学联合出版社, 1997:158-183. [3] Rocio B, Alicia S, Jose H, et al. Angiotensin II type AT2 receptor mRNA expression and renal vasodilation are increased in renal failure [J].Hypertension, 2001, 38(6): 669-673. [4] Dominik N, Muller, Eero MA, et al. Effect of Bosentan on NF-κB, Inflammation, and Tissue Factor in Angiotensin II-Induced End-Organ Damage [J].Hypertension, 2000, 36(10):282. [5] Dominik NM, Ralf Dechend, Eero MA, et al. NF-κB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats [J].Hypertension, 2000, 35(3):193. [6] Forte A, Di Micco G, Galderisi U, et al. Gene expression and morphological changes in surgically injured carotids of spontaneously hypertensive rats [J].J Vasc Res, 2002, 39 (2):114-121. [7] Bonnet F, Cooper ME, Carey RM, et al. Vascular expression of angiotensin type 2 receptor in the adult rat:influence of angiotensin II infusion [J].J Hypertens, 2001, 19(6):1075-1081. [8] Lombardi DM, ViswanathanM, Vio CP, et al. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent [J].Nephron, 2001, 87(1):66-74. |